NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
4.750
+0.140 (3.04%)
At close: Apr 28, 2026, 4:00 PM EDT
4.780
+0.030 (0.63%)
After-hours: Apr 28, 2026, 4:10 PM EDT
NMTC Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Revenue | 11.72 | 12.1 | 3.45 | 3.41 | 2.12 | 0.24 | |
| Revenue Growth (YoY) | 103.78% | 250.35% | 1.33% | 60.73% | 772.60% | -87.39% | |
| Cost of Revenue | 9.13 | 8.94 | 7.44 | 8.44 | 5.17 | 4.2 | |
| Gross Profit | 2.58 | 3.16 | -3.99 | -5.03 | -3.05 | -3.96 | |
| Selling, General & Admin | 7.23 | 7.38 | 7.9 | 6.93 | 6.98 | 6.26 | |
| Operating Expenses | 10.23 | 7.38 | 7.9 | 6.93 | 6.98 | 6.26 | |
| Operating Income | -7.64 | -4.23 | -11.89 | -11.96 | -10.03 | -10.22 | |
| Interest Expense | - | -0.2 | -0.1 | - | - | -0 | |
| Interest & Investment Income | 0.06 | - | - | 0.2 | - | - | |
| Other Non Operating Income (Expenses) | 0.83 | 0.82 | -0.33 | -0.07 | 0.03 | -0.01 | |
| EBT Excluding Unusual Items | -6.76 | -3.61 | -12.32 | -11.83 | -10 | -10.23 | |
| Gain (Loss) on Sale of Assets | - | - | - | -0.03 | - | - | |
| Legal Settlements | - | - | - | - | - | 0.2 | |
| Other Unusual Items | -0.07 | - | - | - | - | 0.08 | |
| Pretax Income | -6.83 | -3.61 | -12.32 | -11.86 | -10 | -9.95 | |
| Net Income | -6.83 | -3.61 | -12.32 | -11.86 | -10 | -9.95 | |
| Net Income to Common | -6.83 | -3.61 | -12.32 | -11.86 | -10 | -9.95 | |
| Shares Outstanding (Basic) | 8 | 7 | 4 | 3 | 3 | 2 | |
| Shares Outstanding (Diluted) | 8 | 7 | 4 | 3 | 3 | 2 | |
| Shares Change (YoY) | 58.14% | 50.03% | 47.69% | 13.27% | 49.56% | 97.52% | |
| EPS (Basic) | -0.91 | -0.54 | -2.76 | -3.93 | -3.75 | -5.58 | |
| EPS (Diluted) | -0.93 | -0.54 | -2.76 | -3.93 | -3.75 | -5.58 | |
| Free Cash Flow | -6.26 | -2.92 | -11.13 | -13.27 | -7.79 | -8.67 | |
| Free Cash Flow Per Share | -0.83 | -0.44 | -2.50 | -4.39 | -2.92 | -4.86 | |
| Gross Margin | 22.03% | 26.11% | -115.42% | -147.58% | -143.93% | - | |
| Operating Margin | -65.25% | -34.94% | -344.26% | -350.84% | -473.14% | -4205.75% | |
| Profit Margin | -58.28% | -29.80% | -356.74% | -348.03% | -471.67% | -4094.60% | |
| Free Cash Flow Margin | -53.42% | -24.13% | -322.39% | -389.45% | -367.67% | -3568.48% | |
| EBITDA | -7.38 | -3.96 | -11.64 | -11.76 | -9.91 | -10.14 | |
| EBITDA Margin | -63.02% | -32.77% | - | - | - | - | |
| D&A For EBITDA | 0.26 | 0.26 | 0.25 | 0.2 | 0.12 | 0.08 | |
| EBIT | -7.64 | -4.23 | -11.89 | -11.96 | -10.03 | -10.22 | |
| EBIT Margin | -65.25% | -34.94% | - | - | - | - | |
| Advertising Expenses | - | 0.17 | 0.11 | 0.17 | 0.27 | 0.34 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.